CalciMedica, Cash vs Current Deferred Revenue Analysis

CALC Stock

2.78 0.03 1.07%

CalciMedica, Common financial indicator trend analysis is way more than just evaluating CalciMedica, Common Stock prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CalciMedica, Common Stock is a good investment. Please check the relationship between CalciMedica, Common Cash and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Cash vs Current Deferred Revenue

Cash vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CalciMedica, Common Stock Cash account and Current Deferred Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between CalciMedica, Common's Cash and Current Deferred Revenue is -0.4. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of CalciMedica, Common Stock, assuming nothing else is changed. The correlation between historical values of CalciMedica, Common's Cash and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of CalciMedica, Common Stock are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Cash i.e., CalciMedica, Common's Cash and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

-0.4

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Cash

Cash refers to the most liquid asset of CalciMedica, Common Stock, which is listed under current asset account on CalciMedica, Common Stock balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from CalciMedica, Common customers. The amounts must be unrestricted with restricted cash listed in a different CalciMedica, Common account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from CalciMedica, Common's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CalciMedica, Common Stock current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

The current year's Issuance Of Capital Stock is expected to grow to about 30.2 M, whereas Selling General Administrative is forecasted to decline to about 14.6 M.

CalciMedica, Common fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Investments	Net Invested Capital	Property Plant And Equipment Gross	Capital Stock	Net Working Capital	Current Deferred Revenue	Short Term Debt	Common Stock	Net Receivables
Total Assets		0.33	0.17	1.0	0.4	-0.84	-0.48	-0.08	0.84	-0.24	-0.54	1.0	-0.26	0.94	0.71	0.17	1.0	0.93	0.72	-0.07	-0.52	0.96	-0.19	-0.16	0.27	-0.15
Other Current Liab	0.33		0.96	0.25	0.58	-0.31	0.16	0.62	0.31	0.31	0.09	0.3	-0.25	0.09	-0.02	0.96	0.3	0.22	-0.15	0.39	0.25	0.18	-0.41	-0.41	0.23	-0.43
Total Current Liabilities	0.17	0.96		0.09	0.53	-0.31	0.3	0.81	0.3	0.46	0.31	0.14	-0.34	-0.1	-0.27	1.0	0.13	0.07	-0.34	0.46	0.42	0.04	-0.42	-0.44	0.3	-0.44
Total Stockholder Equity	1.0	0.25	0.09		0.35	-0.82	-0.51	-0.15	0.82	-0.28	-0.57	1.0	-0.23	0.96	0.74	0.09	1.0	0.93	0.76	-0.11	-0.56	0.97	-0.15	-0.12	0.24	-0.12
Property Plant And Equipment Net	0.4	0.58	0.53	0.35		-0.49	0.53	0.22	0.49	0.72	0.39	0.33	-0.8	0.38	-0.1	0.53	0.34	0.6	-0.29	0.87	0.52	0.49	-0.96	-0.95	0.73	-0.92
Net Debt	-0.84	-0.31	-0.31	-0.82	-0.49		0.11	-0.27	-1.0	-0.14	0.1	-0.82	0.58	-0.74	-0.3	-0.31	-0.82	-0.83	-0.39	-0.2	0.15	-0.88	0.39	0.39	-0.51	0.34
Retained Earnings	-0.48	0.16	0.3	-0.51	0.53	0.11		0.31	-0.11	0.88	0.87	-0.53	-0.53	-0.42	-0.7	0.3	-0.53	-0.22	-0.88	0.85	0.93	-0.31	-0.7	-0.73	0.39	-0.69
Accounts Payable	-0.08	0.62	0.81	-0.15	0.22	-0.27	0.31		0.27	0.51	0.55	-0.09	-0.4	-0.38	-0.61	0.81	-0.11	-0.19	-0.48	0.34	0.51	-0.15	-0.24	-0.28	0.38	-0.25
Cash	0.84	0.31	0.3	0.82	0.49	-1.0	-0.11	0.27		0.15	-0.09	0.82	-0.59	0.74	0.29	0.3	0.82	0.83	0.38	0.21	-0.14	0.88	-0.4	-0.39	0.52	-0.34
Non Current Assets Total	-0.24	0.31	0.46	-0.28	0.72	-0.14	0.88	0.51	0.15		0.92	-0.3	-0.83	-0.27	-0.75	0.46	-0.3	0.01	-0.83	0.95	0.95	-0.09	-0.87	-0.89	0.74	-0.82
Non Currrent Assets Other	-0.54	0.09	0.31	-0.57	0.39	0.1	0.87	0.55	-0.09	0.92		-0.58	-0.65	-0.57	-0.93	0.31	-0.58	-0.33	-0.93	0.77	0.96	-0.39	-0.61	-0.64	0.57	-0.57
Cash And Short Term Investments	1.0	0.3	0.14	1.0	0.33	-0.82	-0.53	-0.09	0.82	-0.3	-0.58		-0.21	0.93	0.73	0.14	1.0	0.91	0.76	-0.14	-0.57	0.95	-0.12	-0.09	0.22	-0.09
Common Stock Shares Outstanding	-0.26	-0.25	-0.34	-0.23	-0.8	0.58	-0.53	-0.4	-0.59	-0.83	-0.65	-0.21		-0.22	0.42	-0.34	-0.21	-0.49	0.4	-0.83	-0.62	-0.42	0.89	0.89	-0.94	0.8
Other Current Assets	0.94	0.09	-0.1	0.96	0.38	-0.74	-0.42	-0.38	0.74	-0.27	-0.57	0.93	-0.22		0.79	-0.1	0.94	0.96	0.75	-0.06	-0.55	0.97	-0.21	-0.17	0.22	-0.18
Other Stockholder Equity	0.71	-0.02	-0.27	0.74	-0.1	-0.3	-0.7	-0.61	0.29	-0.75	-0.93	0.73	0.42	0.79		-0.27	0.74	0.59	0.92	-0.53	-0.87	0.62	0.32	0.36	-0.4	0.32
Total Liab	0.17	0.96	1.0	0.09	0.53	-0.31	0.3	0.81	0.3	0.46	0.31	0.14	-0.34	-0.1	-0.27		0.13	0.07	-0.34	0.46	0.42	0.05	-0.42	-0.44	0.3	-0.44
Total Current Assets	1.0	0.3	0.13	1.0	0.34	-0.82	-0.53	-0.11	0.82	-0.3	-0.58	1.0	-0.21	0.94	0.74	0.13		0.91	0.76	-0.13	-0.57	0.95	-0.13	-0.1	0.22	-0.09
Short Term Investments	0.93	0.22	0.07	0.93	0.6	-0.83	-0.22	-0.19	0.83	0.01	-0.33	0.91	-0.49	0.96	0.59	0.07	0.91		0.55	0.2	-0.3	0.99	-0.46	-0.43	0.47	-0.41
Net Invested Capital	0.72	-0.15	-0.34	0.76	-0.29	-0.39	-0.88	-0.48	0.38	-0.83	-0.93	0.76	0.4	0.75	0.92	-0.34	0.76	0.55		-0.7	-0.96	0.63	0.49	0.52	-0.33	0.48
Property Plant And Equipment Gross	-0.07	0.39	0.46	-0.11	0.87	-0.2	0.85	0.34	0.21	0.95	0.77	-0.14	-0.83	-0.06	-0.53	0.46	-0.13	0.2	-0.7		0.86	0.08	-0.96	-0.97	0.74	-0.93
Capital Stock	-0.52	0.25	0.42	-0.56	0.52	0.15	0.93	0.51	-0.14	0.95	0.96	-0.57	-0.62	-0.55	-0.87	0.42	-0.57	-0.3	-0.96	0.86		-0.39	-0.7	-0.73	0.54	-0.68
Net Working Capital	0.96	0.18	0.04	0.97	0.49	-0.88	-0.31	-0.15	0.88	-0.09	-0.39	0.95	-0.42	0.97	0.62	0.05	0.95	0.99	0.63	0.08	-0.39		-0.34	-0.31	0.41	-0.3
Current Deferred Revenue	-0.19	-0.41	-0.42	-0.15	-0.96	0.39	-0.7	-0.24	-0.4	-0.87	-0.61	-0.12	0.89	-0.21	0.32	-0.42	-0.13	-0.46	0.49	-0.96	-0.7	-0.34		1.0	-0.8	0.95
Short Term Debt	-0.16	-0.41	-0.44	-0.12	-0.95	0.39	-0.73	-0.28	-0.39	-0.89	-0.64	-0.09	0.89	-0.17	0.36	-0.44	-0.1	-0.43	0.52	-0.97	-0.73	-0.31	1.0		-0.79	0.95
Common Stock	0.27	0.23	0.3	0.24	0.73	-0.51	0.39	0.38	0.52	0.74	0.57	0.22	-0.94	0.22	-0.4	0.3	0.22	0.47	-0.33	0.74	0.54	0.41	-0.8	-0.79		-0.8
Net Receivables	-0.15	-0.43	-0.44	-0.12	-0.92	0.34	-0.69	-0.25	-0.34	-0.82	-0.57	-0.09	0.8	-0.18	0.32	-0.44	-0.09	-0.41	0.48	-0.93	-0.68	-0.3	0.95	0.95	-0.8

Click cells to compare fundamentals

CalciMedica, Common Account Relationship Matchups

CalciMedica, Common fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	40.7M	101.8M	69.1M	39.7M	12.2M	11.6M
Other Current Liab	7.6M	4.5M	3.5M	1.7M	2.5M	3.1M
Total Current Liabilities	12.3M	7.0M	4.1M	3.7M	4.0M	4.9M
Total Stockholder Equity	28.4M	94.8M	65.0M	36.0M	8.2M	7.7M
Property Plant And Equipment Net	2.0M	1.9M	2.0M	195K	167K	158.7K
Net Debt	(15.9M)	(33.4M)	(13.4M)	(17.1M)	(5.5M)	(5.8M)
Retained Earnings	(105.8M)	(133.4M)	(169.2M)	(204.8M)	(146.1M)	(153.4M)
Accounts Payable	4.6M	2.5M	527K	2.9M	1.4M	1.9M
Cash	15.9M	33.4M	13.4M	17.3M	5.5M	5.3M
Non Current Assets Total	4.4M	2.6M	2.0M	1.6M	580K	551K
Non Currrent Assets Other	2.4M	580K	29K	1.4M	413K	392.4K
Cash And Short Term Investments	36.0M	95.0M	63.7M	39.1M	11.2M	10.7M
Common Stock Shares Outstanding	1.0M	472.7K	1.5M	1.5M	4.5M	4.7M
Liabilities And Stockholders Equity	40.7M	101.8M	69.1M	39.7M	12.2M	11.6M
Other Current Assets	315K	4.2M	3.4M	1.0M	367K	348.7K
Other Stockholder Equity	2.9M	228.2M	234.2M	40.4M	154.2M	121.4M
Total Liab	12.3M	7.0M	4.1M	3.7M	4.0M	4.9M
Total Current Assets	36.3M	99.2M	67.1M	39.7M	11.6M	11.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether CalciMedica, Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica, Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica, Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica, Common Stock Stock:

How To Invest In CalciMedica,

Details

Is CalciMedica, Stock a good investment?

Details

What is CalciMedica, Common's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CalciMedica, Common. If investors know CalciMedica, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CalciMedica, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.11)

Return On Assets

(0.65)

Return On Equity

(0.84)

The market value of CalciMedica, Common Stock is measured differently than its book value, which is the value of CalciMedica, that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica, Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CalciMedica, Common's market value can be influenced by many factors that don't directly affect CalciMedica, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CalciMedica, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if CalciMedica, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CalciMedica, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CalciMedica, Cash vs Current Deferred Revenue Analysis

Cash vs Current Deferred Revenue

Cash vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Cash

Current Deferred Revenue

CalciMedica, Common fundamental ratios Correlations

CalciMedica, Common Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CalciMedica, Common fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity

Cash	- 1.0	Net Debt
Short Term Debt	- 0.97	Property Plant And Equipment Gross
Current Deferred Revenue	- 0.96	Property Plant And Equipment Gross
Capital Stock	- 0.96	Net Invested Capital
Current Deferred Revenue	- 0.96	Property Plant And Equipment Net
Short Term Debt	- 0.95	Property Plant And Equipment Net